Lotte E. Elshof

834 total citations
10 papers, 558 citations indexed

About

Lotte E. Elshof is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Lotte E. Elshof has authored 10 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 6 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Lotte E. Elshof's work include Breast Cancer Treatment Studies (8 papers), Global Cancer Incidence and Screening (5 papers) and Breast Lesions and Carcinomas (5 papers). Lotte E. Elshof is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Global Cancer Incidence and Screening (5 papers) and Breast Lesions and Carcinomas (5 papers). Lotte E. Elshof collaborates with scholars based in Netherlands, Belgium and India. Lotte E. Elshof's co-authors include Emiel J. Rutgers, Jelle Wesseling, A. Elise van Leeuwen‐Stok, Leen Slaets, Konstantinos Tryfonidis, Ruud M. Pijnappel, Nina Bijker, Victoria Skinner, Nicolas Dif and Flora E. van Leeuwen and has published in prestigious journals such as Annals of Surgery, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Lotte E. Elshof

10 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lotte E. Elshof Netherlands	9	410	317	249	112	76	10	558
Amy Cyr United States	16	420 1.0×	178 0.6×	281 1.1×	98 0.9×	51 0.7×	46	607
F. O’Malley Canada	6	332 0.8×	223 0.7×	209 0.8×	90 0.8×	42 0.6×	9	476
Mary Morrogh United States	14	416 1.0×	276 0.9×	406 1.6×	126 1.1×	98 1.3×	20	745
Kathryn A Carolin United States	10	308 0.8×	297 0.9×	219 0.9×	51 0.5×	41 0.5×	11	586
Lajos Pusztai United States	5	407 1.0×	201 0.6×	240 1.0×	87 0.8×	36 0.5×	5	503
Lars-Gunnar Arnesson Sweden	7	470 1.1×	287 0.9×	311 1.2×	57 0.5×	57 0.8×	8	587
George Papadatos Australia	8	360 0.9×	261 0.8×	168 0.7×	103 0.9×	59 0.8×	15	505
Lisette Stork‐Sloots United States	13	451 1.1×	399 1.3×	159 0.6×	64 0.6×	94 1.2×	49	633
José Vila Italy	11	484 1.2×	291 0.9×	299 1.2×	40 0.4×	59 0.8×	17	546
I. Raoust France	10	321 0.8×	282 0.9×	164 0.7×	128 1.1×	143 1.9×	22	546

Countries citing papers authored by Lotte E. Elshof

Since Specialization

Citations

This map shows the geographic impact of Lotte E. Elshof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lotte E. Elshof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lotte E. Elshof more than expected).

Fields of papers citing papers by Lotte E. Elshof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lotte E. Elshof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lotte E. Elshof. The network helps show where Lotte E. Elshof may publish in the future.

Co-authorship network of co-authors of Lotte E. Elshof

This figure shows the co-authorship network connecting the top 25 collaborators of Lotte E. Elshof. A scholar is included among the top collaborators of Lotte E. Elshof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lotte E. Elshof. Lotte E. Elshof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Seijen, Maartje van, Esther H. Lips, Liping Fu, et al.. (2021). Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast. British Journal of Cancer. 125(10). 1443–1449. 11 indexed citations

Visser, Lindy L., Lotte E. Elshof, Koen Van de Vijver, et al.. (2019). Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS. The American Journal of Surgical Pathology. 43(11). 1574–1582. 13 indexed citations

Visser, Lindy L., Lotte E. Elshof, Michael Schaapveld, et al.. (2018). Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ —A Nested Case–Control Study. Clinical Cancer Research. 24(15). 3593–3601. 31 indexed citations

Elshof, Lotte E., Michael Schaapveld, Emiel J. Rutgers, et al.. (2017). The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study. Breast Cancer Research. 19(1). 26–26. 13 indexed citations

Elshof, Lotte E., Marjanka K. Schmidt, Emiel J. Rutgers, et al.. (2017). Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ. Annals of Surgery. 267(5). 952–958. 51 indexed citations

Groen, Emma J., Lotte E. Elshof, Lindy L. Visser, et al.. (2016). Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS). The Breast. 31. 274–283. 103 indexed citations

Elshof, Lotte E., Michael Schaapveld, Marjanka K. Schmidt, et al.. (2016). Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women. Breast Cancer Research and Treatment. 159(3). 553–563. 47 indexed citations

Elshof, Lotte E., Konstantinos Tryfonidis, Leen Slaets, et al.. (2015). Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study. European Journal of Cancer. 51(12). 1497–1510. 254 indexed citations

Koolen, Bas B., Lotte E. Elshof, Claudette E. Loo, et al.. (2013). Does the pretreatment tumor sampling location correspond with metabolic activity on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy?. European Journal of Radiology. 82(12). 2353–2358. 5 indexed citations

10.

Elshof, Lotte E., Emiel J. Rutgers, Eline E. Deurloo, et al.. (2010). A practical approach to manage additional lesions at preoperative breast MRI in patients eligible for breast conserving therapy: results. Breast Cancer Research and Treatment. 124(3). 707–715. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact